This formulation presents the major hyaluronic acid concentration of Rjdephyne lines (26 MG/ML) and the highest elasto-plasticity properties. It is indicated to increase the volumes and redefinition of the oval face shape, facial lipoatrophy, chin, and mandibular area with a recommended injection in the deep dermis or shallow subcutaneous tissue.
Rjdephyne
Rjdephyne EXTRA
This formulation presents the major hyaluronic acid concentration of Rjdephyne lines (26 MG/ML) and the highest elasto-plasticity properties. It is indicated to increase the volumes and redefinition of the oval face shape, facial lipoatrophy, chin, and mandibular area with a recommended injection in the deep dermis or shallow subcutaneous tissue.
| Gel type | Monophasic gel |
|---|---|
| HA content | 26 mg/mi |
| Cross-linked agent | BDDE |
| Dosage | 1 ml |
| Needles size | 25G |
| Bacterial endotoxin | <0.5Eu/mg |
| Duration | 8-18 months |
| Certificates | CE 0373, ISO 13485 |
| Where to inject | Deep dermis or shallow subcutaneous tissue |
Related products
-
Rjdephyne
Rjdephyne FORTE
-
Rjdephyne
Rjdephyne MEDIUM
-
Rjdephyne
Rjdephyne BODY
